Evidence map›Paper›PMID 21984735›Full record

ArticleThe Journal of infectious diseases2011

High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

Michael A Chattergoon, Jordana S Levine, Rachel Latanich, William O Osburn, David L Thomas, Andrea L Cox

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 55 citations in OpenAlex.

  1. Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026
    Review
  2. Article
  3. Article
  4. Biomarkers in Detection of Hepatitis C Virus Infection.Pathogens (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Innate Immunity in Hepatitis C Virus Infection.Cold Spring Harbor perspectives in medicine · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael A ChattergoonDivision of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Jordana S Levine
Rachel Latanich
William O Osburn
David L Thomas
Andrea L Cox
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Scientific CoreU19AI088791 · NIAID · JOHNS HOPKINS UNIVERSITY · PI RAY, STUART C · 2010 to 2020
$8.2M
Antibody-Mediated Suppression of Antiviral Inflammasome ActivationR01AI108403 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2013 to 2017
$2.2M
Mechanisms of Immune Evasion by Hepatitis C VirusR01AI077757 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2009 to 2012
$1.7M
NIAID NIH HHS R01 AI077757NIAID NIH HHS R01AI077757NIAID NIH HHS R01 AI108403NIAID NIH HHS U19 AI088791NIAID NIH HHS U19 AI09025PHS HHS R0113324
6 · The paper itself

Abstract

backgroundProinflammatory cytokines play a critical role in antiviral immune responses. Large-scale genome studies have found correlations between single-nucleotide polymorphisms (SNPs) in the interleukin (IL) 18 promoter and spontaneous control of hepatitis C virus (HCV), suggesting a role in clearance.

methodsPlasma IL-18, IL-1β, IL-6, IL-8, IL-12, interferon-γ, tumor necrosis factor-α, alanine aminotransferase (ALT), and HCV RNA levels were assessed longitudinally in subjects with known dates of HCV acquisition and analyzed according to IL-18 SNPs and outcome, either spontaneous clearance (SC) (n = 13) or persistent infection (PI) (n = 25).

resultsNo significant change in plasma proinflammatory cytokine expression was observed with the exception of IL-18, which increased in every subject with initial detection of HCV RNA. In every SC subject, IL-18 returned to the preinfection baseline concomitant with HCV control. In PI subjects, IL-18 declined following the acute phase of infection but remained above the preinfection baseline throughout chronic infection and did not correlate with HCV RNA or ALT levels.

conclusionsPlasma IL-18 was an early and the most reliably detected host response to HCV infection measured in blood. Reduced IL-18 production with transition to chronic infection without correlation with HCV RNA or ALT levels suggests modulation of the innate response with persistent infection.

Indexed as

Acute DiseaseAlanine TransaminaseBiomarkersGenotypeHepatitis CHumansInterleukin-18Longitudinal StudiesPolymorphism, Single NucleotideRNA, ViralStatistics, NonparametricAlanine TransaminaseBiomarkersInterleukin-18RNA, Viral

Identifiers

PMID21984735
PMCPMC3203233
OpenAlexW2097787211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.